Special Gazette, 12 March 2024

Contents

  • Diazinon reconsideration – proposed decisions on reconsideration – 1 
  • Attachment A: Active constituent approval(s), product registration(s) and label approval(s) under reconsideration – 3 
  • Attachment B: Statement of Reasons – 5 
  • Attachment C: Information on which the reasons are based – 41 
  • Attachment D: Proposed sample labels for diazinon chemical products – 44

Diazinon proposed regulatory decision

The Australian Pesticides and Veterinary Medicines Authority (APVMA) invites written submissions on the proposed regulatory decision for the reconsideration of diazinon, which was published in the APVMA Special Gazette, 12 March 2024.

All submissions with information related to the scientific information and assessments conducted by the APVMA will be considered prior to finalisation of the reconsideration and publication of the final regulatory decision.

New veterinary chemical product containing a new veterinary active constituent: CosACTHen 0.25 mg/mL Solution for Dogs

The APVMA is considering an application for approval of the new active constituent, tetracosactide and the registration of the product, CosACTHen 0.25mg/mL Solution for Injection for Dogs, for the evaluation of adrenocortical function in dogs.

We invite comments from 5 March 2024 to 1 April 2024 on whether approval of the active constituent and registration of the product should be granted.

The APVMA is able to consider comments relating to the legislative grounds, including:

Subscribe to